GURUFOCUS.COM » STOCK LIST » Latin America » Mexico » MEX » WuXi Biologics (Cayman) Inc (MEX:2269) » Definitions » Policyholder Funds
Switch to:

WuXi Biologics (Cayman) (MEX:2269) Policyholder Funds

View and export this data going back to 2020. Start your Free Trial

Policyholder Funds only applies to insurance companies.

WuXi Biologics (Cayman) (MEX:2269) Business Description

WuXi Biologics (Cayman) logo
Traded in Other Exchanges
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
WuXi Biologics ("WuXi") is a contract development and manufacturing organization, or "CDMO," for biologic drugs. It was founded in 2010 as part of WuXi AppTec and listed on the Hong Kong Stock Exchange in 2017. WuXi provides comprehensive services from conception to commercialization, including drug discovery, clinical and commercial manufacturing, and various support services such as process validation, viral clearance studies, product and cell line characterization, stability studies, and others. It does not conduct clinical trials.